Medtronic Recall Info contains medical and legal information on the recent Sprint Fidelis lead wire recall, including information on the recall, wire problems and latest news.
Austin, TX (PRWEB) November 7, 2007 -- The law firm of Hissey Kientz has announced the launch of its new website, Medtronic Recall Info. The website will provide news and information about the recent recall of Medtronic's Sprint Fidelis lead wires for patients who may have been injured by this product.
Medtronic recalled the Sprint Fidelis leads on October 14, 2007, after learning of five deaths linked to malfunctions. The leads are small wires which connect an implantable cardiac defibrillator to a patient's heart and deliver a jolt of electricity in order to correct an irregular heartbeat, such as during a heart attack.
According to Medtronic, the Sprint Fidelis leads are more than twice as likely to break within 30 months than other lead wires manufactured by the company. When fractures in the wires occur, a defibrillator may fail to deliver a life-saving jolt to a patient's heart during a heart attack, or may cause the device to deliver painful, repeated shocks to the heart.
The Food and Drug Administration has received at least 1,600 reports of patients who have experienced injuries or malfunctions due to problems with the Sprint Fidelis leads. Approximately one-third of these patients suffered unnecessary shocks to their hearts as a result of fractures in the lead wires.
Several patients who were injured after experiencing a malfunction in their Sprint Fidelis leads have filed lawsuits against Medtronic. These lawsuits have alleged that Medtronic continued to sell the lead wires despite the fact that they knew the product posed a greater risk for injury than its other defibrillator wires. Some experts believe that the Sprint Fidelis leads--which are the thinnest ever made by Medtronic--may have been too fragile to be used safely with defibrillators.
Medtronic is already facing more that 1,000 lawsuits over the 2005 recall of some defibrillators manufactured by the company. With more than 268,000 Sprint Fidelis leads currently in use, some financial analysts believe that the company could be facing an even greater number of lawsuits over the Sprint Fidelis recall.
About Hissey Kientz, LLP
Hissey Kientz, LLP is currently accepting cases involving people affected by mesothelioma, ReNu with MoistureLoc, AMO Complete Moisture Plus, Fosamax, the Ortho Evra birth control patch, Zelnorm, MRI contrast dyes, the Bard Composix Kugel mesh patch, hormone replacement therapy and other defective drugs or devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call toll-free at (866) 275-4454.
Source: PRWeb: Legal / Law
See Also
No comments:
Post a Comment